Neuroendocrine aspects of the response to stress

Metabolism: Clinical and Experimental

Volumn 51, Issue 6 SUPPL. 1, 2002, Pages 5-10

  Miller, Diane B ^a   O'Callaghan, James P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; ANTALARMIN; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR 1 ANTAGONIST; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; GLUCOCORTICOID; HYDROCORTISONE; PYRROLOPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ADAPTATION; ADDISON DISEASE; ADRENAL CORTEX; ADRENERGIC SYSTEM; AFFECTIVE NEUROSIS; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CIRCULATION; CORTICOTROPIN RELEASE; CUSHING DISEASE; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG RESEARCH; DRUG SCREENING; FEEDBACK SYSTEM; HOMEOSTASIS; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; METABOLIC ACTIVATION; METABOLIC INHIBITION; MOLECULAR BIOLOGY; NEGATIVE FEEDBACK; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PAIN; PATHOPHYSIOLOGY; PHARMACOLOGICAL BLOCKING; PHYSICAL STRESS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; STRESS; VISCERA;

EID: 0036284570     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.33184     Document Type: Review

References (79)

1. Stress as a medical and scientific idea and its implications
2. Editorial: A healthy body in a healthy mind - And vice versa - The damaging power of "uncontrollable" stress
3. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuroendocrine and target tissue-related causes
4. Protective and damaging effects of stress mediators
5. The neurobiology of stress: From serendipity to clinical relevance
6. Allostasis and allostatic load: Implications for neuropsychopharmacology
7. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion
8. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
9. Job strain, blood pressure and response to uncontrollable stress
10. Sleep as a mediator of the relationship between socioeconomic status and health - A hypothesis
11. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
12. Stress and the adrenocortical control of epinephrine synthesis
13. Animal models of social stress: Effects on behavior and brain neurochemical systems
14. Health psychology: What is an unhealthy environment and how does it get under the skin?
15. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
16. A syndrome produced by diverse nocuous agents
17. Corticotropin releasing hormone, receptor regulation and the stress response
18. The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies
19. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse
20. Biology of posttraumatic stress disorder
21. Understanding stress: Characteristics and caveats
22. Stress-induced sensitization of CRH-ir but not P-CREB-ir responsivity in the rat central nervous system
23. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin
24. Corticotropin releasing factor receptors: Distribution and regulation in brain, pituitary and peripheral tissues
25. Corticotropin releasing factor (CRF)
26. Neurobiology of corticotropin releasing factor receptors and CRF-binding protein; Implications for the treatment of CNS disorders
27. The need of a physiologic and pathophysiologic definition of stress
28. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress
29. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats
30. Corticotropin-releasing hormone in depression and post-traumatic stress disorder
31. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation
32. Knocking out the stress response
33. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress
34. The physiology of corticotropin-releasing hormone deficiency in mice
35. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2
36. Effects of corticotropin releasing hormone on human brain function: An analysis based on auditory evoked potentials
37. Corticotropin-releasing factor (CRF) produces analgesia in humans and rats
38. Evidence for central nervous effects of corticotropin-releasing hormone on gastric acid secretion in humans
39. Regulation of pituitary ACTH secretion during chronic stress
40. Neuroendocrinology
41. The adrenals: Part 1, The adrenal cortex
42. Hypothalamic origin of the metabolic syndrome X
43. The metabolic syndrome - A neuroendocrine disorder
44. Adrenal gland: Structure, function, and mechanisms of toxicity
45. Environmental stress and psychiatric illness
46. Effects of mental stress of myocardial ischemia during daily life
47. Psychosocial work characteristics and psychological strain in relation to low-back pain
48. Individual reactivity and physiology of the stress response
49. The evolution of the stress concept: Stress and cardiovascular disease
50. Psychosocial stress-induced heart reactivity and atherogenesis: Cause or correlation?
51. A defect in the central component of the immune system hypothalamic-pituitary-adrenal axis feedback loop is associated with susceptibility to experimental arthritis and other inflammatory diseases
52. Review of psychosocial stress and asthma: An integrated biopsychosocial approach
53. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation - From obesity to memory deficits
54. Metabolic implications of body fat distribution
55. Does central obesity reflect "Cushing's disease of the omentum"?
56. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities
57. Visceral obesity: A "civilization syndrome"
58. Overweight is risking fate
59. Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism
60. Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes
61. Occupational status, cortisol secretory pattern and visceral obesity in middle-aged men
62. Left ventricular structural characteristics in Cushing's syndrome
63. Cardiac characteristics and post-operative courses in Cushing's syndrome
64. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample
65. Chronic burnout, somatic arousal and elevated salivary cortisol levels
66. Heterogeneity in neuroendocrine and immune responses to brief psychological stressors as a function of autonomic cardiac activation
67. Stress system abnormalities in melancholic and atypical depression: Molecular, pathophysiological, and therapeutic implications
68. The psychobiological basis of posttraumatic stress disorder
69. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
70. CRH: Possible role in eating disorders
71. The coricotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions
72. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress
73. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation
74. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress
75. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates, behavioral, neuroendocrine, and autonomic responses to stress in primates
76. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
77. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse
78. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
79. Caveats in hazard assessment: Stress and neurotoxicity